You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,040,088


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,040,088
Title:Nanoparticulate megestrol formulations
Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
Inventor(s): Hovey; Douglas (Trooper, PA), Pruitt; John (Suwanee, GA), Ryde; Tuula (Malvern, PA)
Assignee: ALKERMES PHARMA IRELAND LIMITED (Dublin, IE)
Application Number:14/536,517
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,040,088
Patent Claim Types:
see list of patent claims
Use; Formulation; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,040,088

Introduction

Understanding the scope and claims of a patent is crucial for inventors, patent holders, and those interested in the intellectual property landscape. This article will delve into the specifics of United States Patent 9,040,088, exploring its claims, scope, and the broader patent landscape it operates within.

What is United States Patent 9,040,088?

To begin, it is essential to identify the subject matter of the patent. However, without specific details provided in the query, we will use general principles to analyze how one would approach this task.

Searching for the Patent

To find detailed information about a specific patent, such as US Patent 9,040,088, you can use the resources provided by the United States Patent and Trademark Office (USPTO).

  • USPTO Public Search Facility: This facility, located in Alexandria, VA, offers access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users[1].
  • Global Dossier: This service allows users to access the file histories of related applications from participating IP Offices, including the IP5 Offices. It provides a comprehensive view of the patent family, classification, and citation data[1].

Patent Claims and Scope

Patent claims define the scope of protection granted by the patent. Here’s how you can analyze them:

Understanding Patent Claims

  • Claim Structure: Patent claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].
  • Claim Language: The language used in claims is critical. It must be clear and concise to avoid ambiguity. The USPTO has emphasized the importance of claim clarity through initiatives such as the Enhanced Patent Quality Initiative[4].

Analyzing the Claims of US Patent 9,040,088

To analyze the specific claims of US Patent 9,040,088, you would need to:

  • Retrieve the Patent Document: Use the USPTO's public search tools to retrieve the full text of the patent.
  • Examine the Claims: Carefully read through the claims section to understand what is being protected. Look for key terms, limitations, and any dependencies between claims.
  • Contextual Understanding: Understand the background and summary of the invention to contextualize the claims.

Patent Scope and Coverage

The scope of a patent is defined by its claims and is a critical aspect of patent law.

Determining Patent Scope

  • Statutory Requirements: A quality patent must meet the statutory requirements for novelty, non-obviousness, and utility as outlined in Title 35 of the U.S. Code[4].
  • Claim Interpretation: The scope of the patent is interpreted based on the claims. This involves understanding the meaning of each term used in the claims and how they relate to the invention as a whole.

Impact on the Patent Landscape

  • Prior Art: The patent's scope is also influenced by prior art, which includes all publicly available information before the patent's filing date. Ensuring that the patent does not infringe on existing prior art is crucial[4].
  • Competitor Analysis: Analyzing the patent landscape involves looking at similar patents and understanding how they relate to your patent. This can help in identifying potential competitors and areas for innovation.

Inventorship and Ownership

Correctly determining inventorship is vital for the validity and enforceability of a patent.

True and Only Inventors

  • Conception and Reduction to Practice: US patent law requires that the true and only inventors be listed. This involves identifying those who conceived the idea and reduced it to practice[5].
  • Legal Implications: Incorrect or incomplete identification of inventors can lead to challenges and potential invalidation of the patent.

Patent Assignment and Ownership Changes

Patent assignments and changes in ownership are also important aspects to consider.

Searching for Assignments

  • Patent Assignment Search: The USPTO provides a database to search for patent assignments and changes in ownership. This is crucial for understanding the current ownership status of a patent[1].

Economic and Research Implications

The USPTO also provides datasets and research tools that can help in analyzing the broader economic and research implications of patents.

Patent Claims Research Dataset

  • Detailed Information: The Patent Claims Research Dataset contains detailed information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014. This dataset can be used to analyze trends and statistics related to patent claims[3].

Best Practices for Patent Analysis

When analyzing a patent, several best practices should be followed:

Clear Definitions

  • Consistent Definition of Patent Quality: The USPTO has emphasized the importance of a consistent definition of patent quality, which includes compliance with statutory requirements and clarity in claims[4].

Use of Tools and Resources

  • USPTO Resources: Utilize the various resources provided by the USPTO, such as the Global Dossier and Public Search Facility, to gather comprehensive information about the patent[1].

Stakeholder Engagement

  • Engage with Stakeholders: Engaging with stakeholders, including examiners and other industry experts, can provide valuable insights into the patent's scope and claims[4].

Key Takeaways

  • Comprehensive Search: Use USPTO resources to conduct a thorough search of the patent and its related applications.
  • Clear Claims: Ensure that the patent claims are clear and concise to avoid ambiguity.
  • Correct Inventorship: Correctly identify the true and only inventors to maintain the validity of the patent.
  • Ownership Changes: Keep track of any changes in ownership or assignments.
  • Economic Analysis: Use datasets like the Patent Claims Research Dataset to analyze broader trends and implications.

FAQs

Q: How can I find detailed information about a specific US patent? A: You can use the USPTO's public search tools, such as the Global Dossier or the Public Search Facility, to find detailed information about a specific US patent[1].

Q: What is the importance of clear claims in a patent? A: Clear claims are essential to avoid ambiguity and ensure that the scope of the patent is well-defined. This is a key aspect of the USPTO's Enhanced Patent Quality Initiative[4].

Q: Why is correct inventorship important? A: Correct inventorship is crucial for the validity and enforceability of a patent. Incorrect or incomplete identification of inventors can lead to challenges and potential invalidation of the patent[5].

Q: How can I track changes in ownership of a patent? A: You can use the USPTO's Patent Assignment Search database to track changes in ownership or assignments of a patent[1].

Q: What resources are available for analyzing patent claims and scope? A: The USPTO provides several resources, including the Patent Claims Research Dataset and the Global Dossier, which can be used to analyze patent claims and scope[1][3].

Sources

  1. USPTO - Search for patents.
  2. USA.gov - U.S. Patent and Trademark Office (USPTO).
  3. USPTO - Patent Claims Research Dataset.
  4. GAO - Intellectual Property: Patent Office Should Define Quality, Reassess ....
  5. Oregon State University - Determining Inventorship for US Patent Applications.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,040,088

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Endo Operations MEGACE ES megestrol acetate SUSPENSION;ORAL 021778-001 Jul 5, 2005 AB RX Yes Yes 9,040,088 ⤷  Subscribe TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,040,088

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 539737 ⤷  Subscribe
Australia 2003230885 ⤷  Subscribe
Australia 2003231071 ⤷  Subscribe
Australia 2006262144 ⤷  Subscribe
Brazil PI0612665 ⤷  Subscribe
Canada 2481390 ⤷  Subscribe
Canada 2508301 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.